• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对比增强三维超声成像技术 Sonazoid 的临床应用:肝细胞癌病变的影像学表现。

Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.

机构信息

Gastroenterological Center, Yokohama City University Medical Center, Yokohama, Kanagawa 232-0024, Japan.

出版信息

Eur J Radiol. 2009 Dec;72(3):425-31. doi: 10.1016/j.ejrad.2008.09.003. Epub 2008 Oct 18.

DOI:10.1016/j.ejrad.2008.09.003
PMID:18930616
Abstract

OBJECTIVES

We investigated clinical utility of contrast-enhanced three-dimensional ultrasound (CE 3D US) imaging with contrast medium Sonazoid for demonstrating characteristic enhancement of hepatocellular carcinoma (HCC).

METHODS

Among 115 focal liver tumors undergoing CE 3D US imaging, 70 HCCs confirmed with contrast-enhanced multi-detector computed tomography, contrast-enhanced magnetic resonance imaging or histopathologic examination were retrospectively analyzed. CE 3D US imaging was performed using Autosweep 3D scan functionality in the early, middle and late phase, after bolus injection of 0.2 ml Sonazoid. The CE 3D tomographic images reconstructed in parallel slices and sonographic angiogram images were independently reviewed by two reviewers. Kappa values were used to assess inter-reviewers' agreement.

RESULTS

TUI images showed most of HCCs were detected with intratumoral vessels and early tumor enhancement in the early phase, expressed homogenous or heterogeneous tumor enhancement in the middle phase, and became hypoechoic or isoechoic in the late phase. The kappa values in the early, middle and late phase for inter-reviewer agreements regarding the characteristic enhancement of tumors were 0.817, 0.774, and 0.785. In addition, TUI images demonstrated satellite foci and tortuous tumor vessels in three orthogonal planes. Sonographic angiogram reconstructed by different rendering modes showed the vessels and tumor stain in spatial view. The spatial configuration of anatomic structures was revealed on basis of both TUI and sonographic angiogram images.

CONCLUSION

CE 3D US imaging, with spatial visualization, is clinically useful to exhibit the characteristic enhancement of HCC tumors objectively.

摘要

目的

我们研究了对比增强三维超声(CE 3D US)成像与造影剂声诺维在显示肝细胞癌(HCC)特征性增强方面的临床应用价值。

方法

在 115 个接受 CE 3D US 成像的局灶性肝肿瘤中,回顾性分析了经增强多排 CT、增强磁共振成像或组织病理学检查证实的 70 个 HCC。CE 3D US 成像使用 Autosweep 3D 扫描功能在早期、中期和晚期,在 SonoVue 0.2ml 团注后进行。平行切片重建的 CE 3D 断层图像和超声造影图像由两名审阅者独立审阅。Kappa 值用于评估审阅者之间的一致性。

结果

TUI 图像显示大多数 HCC 在早期显示肿瘤内血管和早期肿瘤增强,在中期表现为均匀或不均匀的肿瘤增强,在晚期表现为低回声或等回声。肿瘤特征性增强的早期、中期和晚期审阅者之间的 Kappa 值分别为 0.817、0.774 和 0.785。此外,TUI 图像在三个正交平面上显示了卫星灶和扭曲的肿瘤血管。不同渲染模式重建的超声造影图像显示了空间内的血管和肿瘤染色。基于 TUI 和超声造影图像,可以显示解剖结构的空间结构。

结论

CE 3D US 成像具有空间可视化功能,可客观地显示 HCC 肿瘤的特征性增强,具有临床应用价值。

相似文献

1
Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid: findings on hepatocellular carcinoma lesions.对比增强三维超声成像技术 Sonazoid 的临床应用:肝细胞癌病变的影像学表现。
Eur J Radiol. 2009 Dec;72(3):425-31. doi: 10.1016/j.ejrad.2008.09.003. Epub 2008 Oct 18.
2
Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.声诺维增强三维超声在评估经皮射频消融治疗肝细胞癌中的作用。
Eur J Radiol. 2010 Jul;75(1):91-7. doi: 10.1016/j.ejrad.2009.03.021. Epub 2009 Apr 9.
3
Three-dimensional contrast-enhanced sonography of vascular patterns of focal liver tumors: pilot study of visualization methods.肝脏局灶性肿瘤血管模式的三维对比增强超声检查:可视化方法的初步研究
AJR Am J Roentgenol. 2009 Jan;192(1):165-73. doi: 10.2214/AJR.08.1107.
4
Usefulness of contrast-enhanced intraoperative ultrasound using Sonazoid in patients with hepatocellular carcinoma.钆塞酸二钠增强术中超声在肝细胞癌患者中的应用价值。
Ann Surg. 2011 Dec;254(6):992-9. doi: 10.1097/SLA.0b013e31822518be.
5
Evaluation of the therapeutic efficacy of high-intensity focused ultrasound ablation of hepatocellular carcinoma by three-dimensional sonography with a perflubutane-based contrast agent.应用含全氟丁烷超声造影剂三维超声评价高强度聚焦超声治疗肝癌的疗效。
Eur J Radiol. 2010 Aug;75(2):e67-75. doi: 10.1016/j.ejrad.2009.11.022. Epub 2009 Dec 16.
6
Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with sonazoid. Comparison with superparamagnetic iron oxide magnetic resonance images.肝细胞癌的成像:使用声诺维进行血管后期对比增强超声检查的定性和定量分析。与超顺磁性氧化铁磁共振图像的比较。
Oncology. 2008;75 Suppl 1:48-54. doi: 10.1159/000173424. Epub 2008 Dec 17.
7
Sonazoid-enhanced ultrasonography for evaluation of the enhancement patterns of focal liver tumors in the late phase by intermittent imaging with a high mechanical index.使用高机械指数进行间歇性成像的声诺维增强超声检查,以评估肝脏局灶性肿瘤晚期的增强模式。
J Ultrasound Med. 2009 Apr;28(4):439-48. doi: 10.7863/jum.2009.28.4.439.
8
A study on the inconsistency of arterial phase hypervascularity detection between contrast-enhanced ultrasound using sonazoid and gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid magnetic resonance imaging of hepatocellular carcinoma lesions.一项关于使用 SonoVue 超声造影与钆塞酸二葡甲胺磁共振成像检测肝细胞癌病灶动脉期高增强一致性的研究。
J Med Ultrason (2001). 2021 Apr;48(2):215-224. doi: 10.1007/s10396-021-01086-2. Epub 2021 Mar 15.
9
Assessment of arterial-phase hyperenhancement and late-phase washout of hepatocellular carcinoma-a meta-analysis of contrast-enhanced ultrasound (CEUS) with SonoVue® and Sonazoid®.评估肝细胞癌的动脉期增强和晚期廓清: SonoVue® 和 Sonazoid® 超声造影的荟萃分析。
Eur Radiol. 2024 Jun;34(6):3795-3812. doi: 10.1007/s00330-023-10371-2. Epub 2023 Nov 22.
10
Correlation between contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of resected hepatocellular carcinoma.使用 SonoVue 增强术中超声与切除的肝细胞癌组织学分级的相关性。
AJR Am J Roentgenol. 2011 Jun;196(6):1314-21. doi: 10.2214/AJR.10.4310.

引用本文的文献

1
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.AFSUMB关于使用声诺维进行超声造影临床实践的共识声明与建议。
J Med Ultrasound. 2020 May 25;28(2):59-82. doi: 10.4103/JMU.JMU_124_19. eCollection 2020 Apr-Jun.
2
The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid.AFSUMB关于使用声诺维进行超声造影临床实践的共识声明与建议。
Ultrasonography. 2020 Jul;39(3):191-220. doi: 10.14366/usg.20057. Epub 2020 Apr 27.
3
Application of new ultrasound techniques for focal liver lesions.
新型超声技术在肝脏局灶性病变中的应用
J Med Ultrason (2001). 2020 Apr;47(2):215-237. doi: 10.1007/s10396-019-01001-w. Epub 2020 Jan 16.
4
Comparison of vascularity observed using contrast-enhanced 3D ultrasonography and pathological changes in patients with hepatocellular carcinoma after sorafenib treatment.索拉非尼治疗后肝细胞癌患者使用对比增强三维超声检查观察到的血管情况与病理变化的比较。
J Cancer. 2018 Jun 14;9(13):2408-2414. doi: 10.7150/jca.24236. eCollection 2018.
5
Application of real-time three-dimensional contrast-enhanced ultrasound using SonoVue for the evaluation of focal liver lesions: a prospective single-center study.使用声诺维的实时三维对比增强超声在肝局灶性病变评估中的应用:一项前瞻性单中心研究。
Am J Transl Res. 2018 May 15;10(5):1469-1480. eCollection 2018.
6
Quantitative Three-Dimensional Dynamic Contrast-Enhanced Ultrasound Imaging: First-In-Human Pilot Study in Patients with Liver Metastases.定量三维动态对比增强超声成像:肝转移患者的首例人体初步研究。
Theranostics. 2017 Aug 23;7(15):3745-3758. doi: 10.7150/thno.20329. eCollection 2017.
7
Contrast-enhanced 3D ultrasonography in minute hepatocellular carcinoma.微小肝细胞癌的对比增强三维超声检查
J Med Ultrason (2001). 2011 Jan;38(1):3-12. doi: 10.1007/s10396-010-0283-6. Epub 2010 Sep 16.
8
Low mechanical index contrast mode versus high mechanical index contrast mode: which is a more sensitive method for detecting Sonazoid microbubbles in the liver of normal subjects?低机械指数对比模式与高机械指数对比模式:哪种是检测正常受试者肝脏中索拉佐德微泡更灵敏的方法?
J Med Ultrason (2001). 2016 Apr;43(2):211-7. doi: 10.1007/s10396-015-0685-6. Epub 2015 Nov 14.
9
Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.使用Sonazoid的超声造影在肝细胞癌中的作用:来自10年经验的证据
J Gastroenterol. 2016 May;51(5):421-33. doi: 10.1007/s00535-015-1151-3. Epub 2015 Dec 22.
10
Advances in ultrasound systems for hepatic lesions in Japan.日本肝脏病变超声系统的进展。
J Med Ultrason (2001). 2015 Jul;42(3):297-301. doi: 10.1007/s10396-015-0630-8.